Clinical trial
Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy
NCT02523001 is registered in ClinicalTrials.gov with University of Bari as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy
- Lead sponsor
- University of Bari
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- July 31, 2015
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.